Honey (Mellis)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Hepatoprotectors

Included in the formulation
  • Bellastesin
    pills inwards 
    TATHIMFARMPREPARATY, JSC     Russia
  • Hepttrong
    solution w / m 
    NUVOMED, ​​LLC     Russia
  • Cryomelt MN
    solution PC 
    ALFATREYD, LLC     Russia
  • MetroPro GP
    solution PC 
    CANON-2, LLC     Russia
    • АТХ:

    A.05.B.A   Preparations for the treatment of liver diseases

    Pharmacodynamics:

    An aqueous solution of honey. It has membrane-stabilizing properties, has an antioxidant effect. Increases the antitoxic function of the liver.

    Pharmacokinetics:

    Not studied.

    Indications:

    It is used for the treatment of chronic hepatitis, fatty liver disease. Used for toxic liver damage.

    ICD-10

    XI.K70-K77.K71   Toxic liver disease

    XI.K70-K77.K73.9   Chronic hepatitis, unspecified

    XI.K70-K77.K76.0   Fatty degeneration of the liver, not elsewhere classified

    Contraindications:

    Age to 18 years, pregnancy and lactation, individual intolerance.

    Carefully:

    Diabetes.

    Pregnancy and lactation:

    Recommendations for FDA - category is not defined. Contraindicated in pregnancy and lactation.

    Dosing and Administration:

    Subcutaneously, 1 ml 1 time per day. The course of treatment is 10-20 days.

    The highest daily dose: 1 ml.

    The highest single dose: 1 ml.

    Side effects:

    Allergic reactions.

    Overdose:

    Cases of overdose are not described.

    Treatment is symptomatic.

    Interaction:

    Clinically significant interactions are not described.

    Special instructions:

    Storage at 15-25 ° C FROM, do not freeze.

    Instructions
    Up